Free Trial

Ovid Therapeutics (OVID) SEC Filings & 10K Form

Ovid Therapeutics logo
$0.32 +0.01 (+2.66%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$0.32 0.00 (-0.19%)
As of 05/2/2025 07:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Ovid Therapeutics SEC Filings

DateFilerForm TypeView
05/02/2025
3:09 PM
Ovid Therapeutics (Filer)
Form PRE 14A
03/11/2025
8:08 AM
Ovid Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/11/2025
7:51 AM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2025
3:08 PM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2025
3:42 PM
Ovid Therapeutics (Issuer)
PAPADOPOULOS STELIOS (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/04/2025
3:44 PM
Ovid Therapeutics (Issuer)
PAPADOPOULOS STELIOS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
6:55 PM
ALEXANDER MARGARET A. (Reporting)
Ovid Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
6:55 PM
Ovid Therapeutics (Issuer)
Rona Jeffrey A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
6:55 PM
LEVIN JEREMY M (Reporting)
Ovid Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
4:41 PM
Madison Avenue Partners, LP (Filed by)
Ovid Therapeutics (Subject)
Form SCHEDULE 13G/A
02/13/2025
4:15 PM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2025
8:18 AM
ALEXANDER MARGARET A. (Reporting)
Ovid Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:15 PM
Bernstein Karen (Reporting)
Ovid Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:15 PM
Duncan Barbara Gayle (Reporting)
Ovid Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:15 PM
Friedman Bart (Reporting)
Ovid Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:15 PM
Fitzgerald Kevin Joseph (Reporting)
Ovid Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
5:01 PM
EcoR1 Capital, LLC (Filed by)
Ovid Therapeutics (Subject)
Form SC 13G/A
09/11/2024
4:36 PM
ALEXANDER MARGARET A. (Reporting)
Ovid Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/11/2024
4:38 PM
ALEXANDER MARGARET A. (Reporting)
Ovid Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
3:57 PM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
7:02 AM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
7:03 AM
Ovid Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/02/2024
4:22 PM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2024
7:04 AM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2024
6:10 AM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
4:19 PM
Ovid Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/14/2024
7:11 AM
Ovid Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2024
7:03 AM
Ovid Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:OVID) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners